Highest-materiality recent filing
JBT Marel declares $0.10 dividend, authorizes $200M buyback effective May 18
Quarterly dividend of $0.10 per share, payable June 9, 2026 to holders of record May 26, 2026.
JBT Marel Q1 revenue $936M (+10% YoY), EPS $0.86, adj. EPS $1.58; reiterates FY2026 outlook
Orders totaled $1.07B, book-to-bill 1.14x; revenue $936M (+10% YoY, ~6% FX benefit).
JBT Marel Investor Day: 2025 revenue $3.8B, Adj EBITDA 15.8%, targets 5-7% annual growth
2025 revenue $3.8B, adjusted EBITDA margin 15.8%; expects 5-7% annual revenue CAGR over 3 years.
JBT Marel reports FY2025 revenue $3.8B, adj. EBITDA $600M; guides FY2026 growth 5-7%
FY2025 revenue $3.8B, record Q4 revenue exceeding $1.0B; adjusted EBITDA $600M (15.8% margin).
JBT Marel Q3 adj. EPS $1.94 beats; raises FY2025 revenue and EPS guidance
Q3 revenue $1.0B, adj. EBITDA $171M (17.1% margin), adj. EPS $1.94; orders $946M.
JBT Marel closes $575M 0.375% convertible notes due 2030; net proceeds ~$506M
$575M aggregate principal (incl. $75M greenshoe) of 0.375% convertible senior notes due 2030.
JBT Marel launches $500M convertible notes offering; amends credit facility to lower borrowing costs
Offering of $500M convertible senior notes due 2030 (plus $75M option) to QIBs under Rule 144A.
JBT Marel Reports Q2 2025 Results, Exceeds Guidance, Re-establishes Full Year Forecast
Q2 revenue $935M, orders $938M, backlog $1.4B, with over half revenue from recurring sources.
JBT Marel Q1 net loss $173M; adj EPS $0.97; suspends FY guidance on tariff uncertainty
Revenue $854M, net loss from continuing ops $173M, GAAP EPS $(3.35); adjusted EPS $0.97.
Marel 2024 revenue EUR 1.64B, net loss EUR 25M vs prior year profit
Revenue of EUR 1,642.7 million, down 4.6% YoY from EUR 1,721.4M.
JBT Marel posts Q4 record orders; raises cost synergies to $150M; guides FY25 adj EPS $5.50-6.10
JBT standalone Q4 record orders $523M; FY24 revenue $1,716M (+3%), adj EBITDA $295M (+8%).
JBT Marel completes compulsory acquisition of remaining Marel shares
Compulsory acquisition closed Feb 4, 2025; remaining Marel shareholders received ~EUR 23.6M cash and 493,150 JBT Marel shares.
JBT Marel files pro forma financials for Marel deal; combined net loss $41M in FY2023
Marel holders representing 97.5% of shares accepted; squeeze-out redemption period ends Jan 30, 2025.
JBT Marel completes acquisition of Marel hf.; issues ~19.5M shares, pays ~EUR 927M cash
Achieved 97.5% acceptance; Marel shareholders received EUR 926.6M cash and 19.5M JBTM shares.
JBT achieves 97.5% Marel shareholder acceptance, will complete acquisition Jan 2, 2025
Marel shareholders tendered 735.3M shares (97.5%), exceeding the 90% minimum acceptance condition.
JBT receives all regulatory clearances for Marel acquisition; offer expires Dec 20, 2024
European Commission cleared transaction on Nov 26, 2024 after Phase 1 review.
Marel 9M 2024 revenue EUR 1,214.7M (-4.6% YoY); net profit EUR 2.7M vs EUR 22.3M a year earlier.
JBT Q3 revenue $454M (+12%), adj. EPS $1.50 (+35%), reiterates FY 2024 guidance
Q3 income from continuing ops $38M (+23%); diluted EPS $1.18 (+22%).
JBT extends Marel takeover offer deadline to Nov 11, 2024 or 3 weeks post regulatory clearances
Offer expiration extended from Sept 2 to earlier of Nov 11, 2024 or three weeks after all regulatory clearances secured.
JBT provides Marel H1 2024 financials and pro forma combined data for takeover
Marel H1 2024 revenue €827.8M vs €869.8M YoY; net loss €1.1M vs profit €12.2M.
JBT shareholders approve stock issuance for Marel acquisition; over 30M votes in favor
Special meeting on Aug 8, 2024; 30,077,405 shares (94.5% of outstanding) present.
JBT Q2 revenue $402M (-6% YoY), EPS $0.95; Marel combination progressing, offer expires Sept 2
Q2 revenue $402M (-6% YoY); income from cont ops $31M (+8%); GAAP EPS $0.95 (+7%), adj EPS $1.05 (+8%).
JBT amends $1.3B credit facility to permit Marel takeover offer
Second Amendment to existing $1.3B revolving credit agreement executed May 17, 2024.
Q1 revenue $392M (+1% YoY); GAAP EPS $0.71 (+34%); adjusted EPS $0.85 (+39%).
Offer: €3.60/share cash, 0.0407 JBT shares, or combination (65% stock/35% cash mix); Marel shareholders receive ~€950M cash and 38% of combined company.
Offer price EUR 3.60 per share cash, or 0.0407 JBT shares; total cash ~EUR 950M; Marel shareholders get ~38% of combined co.
JBT Q4 EPS $1.64 (+69%); adj EPS $1.40; FY adj EBITDA margin 16.4%; Marel offer €3.60
Q4 revenue $445M (+1%); net income $53M (+69%); adjusted EBITDA $81M, margin 18.2% (+260 bps).
JBT to acquire Marel at €3.60 per share, valuing Marel equity at ~€2.7B and enterprise value at ~€3.5B (incl. net debt).
JBT receives extension to Jan 19 for Marel takeover offer decision
Deadline extended from Jan 5 to Jan 19, 2024 by FSA of Central Bank of Iceland.
JBT proposes €3.40/share acquisition of Marel hf, 46% premium, ~€3.4B EV
JBT submitted enhanced €3.40 per share offer (ISK511) for Marel; 46% premium to Nov 23, 2023 unaffected price.
JBT confirms non-binding proposal to acquire Marel; Eyrir Invest with 24.7% supports exclusivity
JBT submitted non-binding initial proposal to acquire all shares of Marel hf., listed on Nasdaq Iceland and Euronext Amsterdam.
Income from continuing ops $31M, EPS $0.95 (+19%); adjusted EPS $1.11 (+16%).
JBT Q2 continuing ops adj. EPS $0.97 beat implied guidance; AeroTech sale closed for $800M
Revenue from continuing ops $428M (+9% YoY); income $28M; adjusted EBITDA $71M (+34%) with margin 16.7%.
JBT gets lender consent for AeroTech sale to Oshkosh; subsidiary guarantors released
Limited Consent entered June 9, 2023, gives lenders' approval for JBT's sale of AeroTech subsidiary to Oshkosh Corporation.
JBT sells AeroTech to Oshkosh for $800M cash; expects Q3 2023 close
All-cash sale valued at $800M; multiple ~14.7x trailing 4Q adjusted EBITDA as of March 31, 2023.
James L. Marvin, the Executive Vice President and Chief Legal Officer of JBT Marel Corporation (the “Company”), announced his intention to retire on May 31, 2025.
C. Maury Devine resigned from the Company’s Board of Directors (the “Board”).
appointed Svafa Gronfeldt, Olafur S. Gudmundsson, Arnar Thor Masson and Ann Savage (collectively, the “New Directors”) to the Board
appointed Svafa Gronfeldt, Olafur S. Gudmundsson, Arnar Thor Masson and Ann Savage (collectively, the “New Directors”) to the Board
appointed Svafa Gronfeldt, Olafur S. Gudmundsson, Arnar Thor Masson and Ann Savage (collectively, the “New Directors”) to the Board
appointed Svafa Gronfeldt, Olafur S. Gudmundsson, Arnar Thor Masson and Ann Savage (collectively, the “New Directors”) to the Board
On the Closing Date, Arni Sigurdsson was appointed as President of the Company.
On February 27, 2024, Emmanuel Lagarrigue, a member of the Board of Directors (the “Board”) of John Bean Technologies Corporation (the “Company”) and the Board’s Audit Committee and Governance and Sustainability Committee, resigned from the Board effective as of February 27, 2024.
On August 16, 2022, the Board of Directors of the Company appointed Luiz “Augusto” Rizzolo to serve as the Company’s Executive Vice President, President Diversified Food & Health, effective October 1, 2022.
On August 15, 2022, Carlos Fernandez, Executive Vice President, President Diversified Food & Health, of John Bean Technologies Corporation (the “Company”) resigned from such position, effective October 1, 2022.
James E. Goodwin, former Chairman and CEO of UAL Corporation, will also retire from the Board at the Company’s Annual Meeting of Stockholders in May in accordance with the Company’s Board retirement policy.
James M. Ringler, a member of the Company’s original Board, determined that he will retire from the Board effective at the May 2022 Annual Meeting of Stockholders.
Max materiality 0.90 · Median 0.70 · Most common event m_and_a